Top compounds associated with response to LINC00675


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC -0.086 0.02
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.089 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.092 0.02
mRNA indisulam CTRPv2 pan-cancer AAC 0.08 0.02
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.096 0.02
mRNA Mitomycin-C CTRPv2 pan-cancer AAC 0.084 0.02
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.08 0.03
mRNA Nutlin-3 CTRPv2 pan-cancer AAC 0.083 0.03
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.091 0.03
mRNA L-685458 CTRPv2 pan-cancer AAC 0.088 0.03
Download CSV